We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$487M
AUM Growth
+$27.9M
Cap. Flow
-$1.78M
Cap. Flow %
-0.36%
Top 10 Hldgs %
38.41%
Holding
369
New
37
Increased
143
Reduced
151
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Healthcare 4.02%
3 Financials 2.55%
4 Consumer Discretionary 2.48%
5 Communication Services 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
351
Citigroup
C
$228B
-4,206
Closed -$215K
CDL icon
352
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$404M
-6,091
Closed -$241K
CVM icon
353
CALL
CEL-SCI Corp
CVM
$26.6M
-10
Closed -$204K
DD icon
354
DuPont de Nemours
DD
$19.5B
-3,988
Closed -$266K
EVRG icon
355
Evergy
EVRG
$18.9B
-3,597
Closed -$213K
HDV
356
iShares Core High Dividend ETF
HDV
$15B
-12,760
Closed -$207K
IAU icon
357
iShares Gold Trust
IAU
$64.8B
-30,193
Closed -$1.03M
ILCG icon
358
iShares Morningstar Growth ETF
ILCG
$3.25B
-7,980
Closed -$374K
IMNN icon
359
Imunon
IMNN
$6.77M
-82
Closed -$60K
IYW icon
360
iShares US Technology ETF
IYW
$25.2B
-7,816
Closed -$527K
MINT icon
361
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
-2,321
Closed -$236K
MTUM icon
362
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
-3,588
Closed -$470K
NBIX icon
363
Neurocrine Biosciences
NBIX
$16.5B
-1,875
Closed -$229K
REGN icon
364
Regeneron Pharmaceuticals
REGN
$82.1B
-329
Closed -$206K
REZI icon
365
Resideo Technologies
REZI
$3.67B
-16,698
Closed -$196K
SYK icon
366
Stryker
SYK
$134B
-1,212
Closed -$218K
BMY.RT
367
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-10,122
Closed -$36K
TACO
368
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
-14,856
Closed -$88K
ATVI
369
DELISTED
Activision Blizzard
ATVI
-2,742
Closed -$208K

Similar funds

Calton & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Calton & Associates held 369 positions worth $487M, up 6.1% from $459M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Calton & Associates's Q3 2020 filing shows 37 new, 143 increased, 151 reduced and 21 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 25,801 shares worth $970K. The largest sale was iShares Russell 1000 Value ETF, an estimated $4.68M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Calton & Associates's largest Q3 2020 buy was SPDR Gold MiniShares Trust: 25,801 shares worth $970K.
  • Calton & Associates added most to iShares Core Universal USD Bond ETF in Q3 2020, an estimated $7.73M increase.
  • Calton & Associates's biggest Q3 2020 reduction was iShares Russell 1000 Value ETF, cutting an estimated $4.68M.
  • Calton & Associates fully exited iShares Gold Trust in Q3 2020, selling an estimated $1.03M.
  • Calton & Associates's ten largest holdings make up 38% of its $487M portfolio in Q3 2020.
  • Calton & Associates opened 37 new positions and closed 21 in Q3 2020.
  • Calton & Associates's portfolio value rose 6.1% quarter-over-quarter to $487M.

Based on Calton & Associates's 13F filing for Q3 2020, filed 30 Oct 2020.